- Home
- SEGG vs KPRX Comparison
SEGG vs KPRX Comparison
Compare SEGG & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEGG | KPRX |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 10.6M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SEGG | KPRX |
|---|---|---|
| Price | $1.25 | $2.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 33.7K | 11.4K |
| Earning Date | 11-19-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,779,057.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.42 | $1.76 |
| 52 Week High | $4.95 | $2.91 |
Technical Indicators
Market Signals| Indicator | SEGG | KPRX |
|---|---|---|
| Relative Strength Index (RSI) | 26.27 | 26.13 |
| Support Level | $0.90 | $1.94 |
| Resistance Level | $1.59 | $2.72 |
| Average True Range (ATR) | 0.23 | 0.07 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 6.88 | 2.45 |
Price Performance
Historical ComparisonAbout SEGG Lottery.com Inc.
Sports Entertainment Gaming Global Corp is a world-wide sports, entertainment and gaming company operating at the intersection of digital content, fan engagement and regulated gaming. It is building an integrated ecosystem designed to connect fans to the games, events and experiences it care about in compliant, technology-enabled environments. It is operated as a single-reporting unit focused on its lottery and gaming platform, and its organizational structure, internal reporting systems, and resource allocation processes were aligned accordingly. The company owns and operates three premium domain brands: Sports.com, Concerts.com, and Lottery.com representing the company's three operating focuses: Sports, Entertainment, and Gaming.
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.